Search Results - "Keber, I"

VARIOUS HORMONAL REPLACEMENT THERAPIES AND RISK FACTORS FOR ATHEROSCLEROSIS by Źegura, B, Guzic-Salobir, B, Sebestjen, M, Keber, I

Get full text

Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia by ŠEBEŠTJEN, M., ŽEGURA, B., KEBER, I.

“… Šebeštjen M, Žegura B, Keber I (Department of Angiology, Hospital of Internal Medicine, University Clinical Centre, Ljubljana, Slovenia). Both cerivastatin…”
Get full text

Heart failure clinic in a community hospital improves outcome in heart failure patients by Lainscak, M, Keber, I

Get full text

Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women by Gužič‐Salobir, B., Keber, I., Seljeflot, I., Arnesen, H., Vrabič, L.

“… Gužič‐Salobir B, Keber I, Seljeflot I, Arnesen H, Vrabič L (University Medical Centre, Ljubljana, Slovenia; Ullevaal University Hospital, Oslo, Norway; and…”
Get full text

Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease by Mavri, A, Gužič-Salobir, B, Salobir-Pajnič, B, Keber, I, Stare, J, Stegnar, M

“…Acute myocardial infarction (AMI) is more frequent in winter months than in summer months. The aetiologic mechanisms underlying this seasonal pattern are…”
Get full text

Carotid intima-media thickness in young patients with familial hypercholesterolaemia by Lavrencic, A., Kosmina, B., Keber, I., Videcnik, V., Keber, D.

“…OBJECTIVE: To assess the extent of early atherosclerotic changes of the carotid arteries in young patients with familial hypercholesterolaemia (FH) detected as…”
Get full text

Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia by Sebestjen, M, Zegura, B, Guzic-Salobir, B, Keber, I

“…A characteristic feature of patients with heterozygous familial hypercholesterolemia (FH) is the premature occurrence of coronary artery disease because of…”
Get more information

Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013 by Kotseva, Kornelia, De Bacquer, Dirk, Jennings, Catriona, Gyberg, Viveca, De Backer, Guy, Rydén, Lars, Amouyel, Philippe, Bruthans, Jan, Cifkova, Renata, Deckers, Jaap W, De Sutter, Johan, Fraz, Zlatko, Graham, Ian, Keber, Irena, Lehto, Seppo, Moore, David, Pajak, Andrzej, Wood, David

“…The EUROASPIRE (European Action on Secondary and Primary Prevention by Intervention to Reduce Events) cross-sectional surveys describe time trends in lifestyle…”
Get full text

Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients by Kotseva, Kornelia, MD, PhD, De Bacquer, Dirk, PhD, Jennings, Catriona, PhD, Gyberg, Viveca, MD, PhD, De Backer, Guy, MD, PhD, Rydén, Lars, MD, PhD, Amouyel, Philippe, MD, PhD, Bruthans, Jan, MD, PhD, Cifkova, Renata, MD, PhD, Deckers, Jaap W., MD, PhD, De Sutter, Johan, MD, PhD, Fraz, Zlatko, MD, PhD, Graham, Ian, MD, Keber, Irena, MD, PhD, Lehto, Seppo, MD, PhD, Moore, David, MD, Pajak, Andrzej, MD, PhD, Wood, David, MD, MSc

“…Consecutive patients with coronary disease (>=18 to <70 years of age) were identified from hospital discharge lists: 1) coronary artery bypass grafting; 2)…”
Get full text

The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women by Žegura, Branka, Gužič-Salobir, Barbara, Šebeštjen, Miran, Keber, Irena

“…OBJECTIVE:Androgenic progestins such as norethisterone acetate (NETA) may influence the effect of estradiol (E2) therapy. We compared the influence of oral E2,…”
Get full text

BLOOD PRESSURE MANAGEMENT IN PATIENTS AFTER HOSPITALIZATION FOR HEART FAILURE: P 555 by Keber, I, Lainscak, Mitja

Get full text

Recall of lifestyle advice in patients recently hospitalised with heart failure: A EuroHeart Failure Survey analysis by Lainščak, Mitja, Cleland, John G.F., Lenzen, Mattie J., Nabb, Samantha, Keber, Irena, Follath, Ferenc, Komajda, Michel, Swedberg, Karl

“…Background There are limited data on recall and implementation of lifestyle advice in patients with heart failure (HF). Aim To investigate what advice patients…”
Get full text

Physical Training Improves Flow-Mediated Dilation in Patients With the Polymetabolic Syndrome by Lavrencic, Alea, Salobir, Barbara Guzic, Keber, Irena

“…ABSTRACTEndothelial dysfunction that can be detected as impaired flow-mediated dilation by ultrasonography is an early event in atherogenesis and has been…”
Get full text

Tissue plasminogen activator release in chronic venous hypertension due to heart failure by Keber, I, Keber, D, Stegnar, M, Vene, N

“…In order to study the effects of chronic venous hypertension due to heart failure on blood fibrinolytic activity, tissue plasminogen activator (t-PA) antigen,…”
Get more information

Aspirin decreases fibrinolytic potential during venous occlusion, but not during acute physical activity by Keber, I, Jereb, M, Keber, D

“…It has previously been observed that aspirin diminishes the increase in blood fibrinolytic activity during arm venous occlusion. We studied the duration of…”
Get more information

Validation of Self Assessment Patient Knowledge Questionnaire for Heart Failure Patients by Lainscak, Mitja, Keber, Irena

“…Background: Several studies showed insufficient knowledge and poor compliance to non-pharmacological management in heart failure patients. Only a limited…”
Get full text

1465 Long Term Improvement of Heart Failure Patient's Knowledge Receiving Care in The Heart Failure Clinic by Lainscak, M., Keber, I.

Get full text

Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure by Jug, Borut, Salobir, Barbara Gužič, Vene, Nina, Šebeštjen, Miran, Šabovič, Mišo, Keber, Irena

“…Heart failure is characterized by activation of the immune system which is strongly associated with disease severity and outcome. We sought to compare the…”
Get full text

Nonpharmacologic Measures and Drug Compliance in Patients with Heart Failure: Data from the EuroHeart Failure Survey by Lainščak, Mitja, MD, PhD, Cleland, John G.F., MD, PhD, Lenzen, Mattie J., MSc, Keber, Irena, MD, PhD, Goode, Kevin, BEng, PhD, Follath, Ferenc, MD, Komajda, Michel, MD, PhD, Swedberg, Karl, MD, PhD

“…Advice on lifestyle, diet, vaccination, and therapy are part of the standard management of heart failure (HF). However, there is little information on whether…”
Get full text

Patient's View of Heart Failure: From the Understanding to the Quality of Life by Lainscak, Mitja, Keber, Irena

“…Background:: Non-pharmacological management is one of heart failure treatment cornerstones. Despite its importance several studies showed lack of clinical…”
Get full text